These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 14742676)

  • 1. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
    Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G
    Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
    Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
    Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
    J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
    Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
    Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
    Fiedler MA; Wernke-Dollries K; Stark JM
    Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
    Shumway SD; Miyamoto S
    Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
    Tergaonkar V; Bottero V; Ikawa M; Li Q; Verma IM
    Mol Cell Biol; 2003 Nov; 23(22):8070-83. PubMed ID: 14585967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA; Owens MW; Grisham MB
    Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum.
    Qin Z; Wang Y; Chasea TN
    Brain Res Mol Brain Res; 2000 Sep; 80(2):111-22. PubMed ID: 11038244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production.
    Haas M; Page S; Page M; Neumann FJ; Marx N; Adam M; Ziegler-Heitbrock HW; Neumeier D; Brand K
    J Leukoc Biol; 1998 Mar; 63(3):395-404. PubMed ID: 9500529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
    Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
    Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.
    Hellerbrand C; Jobin C; Iimuro Y; Licato L; Sartor RB; Brenner DA
    Hepatology; 1998 May; 27(5):1285-95. PubMed ID: 9581682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
    Dai Y; Rahmani M; Grant S
    Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
    Mukhopadhyay A; Manna SK; Aggarwal BB
    J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells.
    Robbesyn F; Garcia V; Auge N; Vieira O; Frisach MF; Salvayre R; Negre-Salvayre A
    FASEB J; 2003 Apr; 17(6):743-5. PubMed ID: 12586748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced proteolysis of IkappaBalpha and IkappaBbeta proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-kappaB activation.
    Kim HT; Qiang W; Wong PK; Stoica G
    J Neurovirol; 2001 Oct; 7(5):466-75. PubMed ID: 11582519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition.
    Pajonk F; Pajonk K; McBride WH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1025-32. PubMed ID: 10863075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
    Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.
    Milligan SA; Nopajaroonsri C
    Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.